The ratio of VEGF positive staining was significantly lower in the tumor treated with Ad5/F35-XAF1 than that in the tumor treated with Ad5/F35-Ctrl (0.91% ± 0.17% vs 8.12 % ± 0.74%, P < 0.01, Fig. 5D, right panel). This evidence concerns the gene VEGFA and neoplasm.